戻る Agenda
Session 5: Track A: Cybersecurity
Session Chair(s)
Marc Lamoureux
Manager, Digital Health Division, Medical Devices Directorate
Health Canada, Canada
Increases in the level of interconnectedness and data exchange between medical devices have large benefits to patients and the healthcare system but can leave devices vulnerable to unauthorized access. These vulnerabilities can negatively impact safety by causing diagnostic or therapeutic errors, or by affecting clinical operations. Health Canada, as the federal regulator of medical device safety and effectiveness, will now be considering cybersecurity vulnerabilities in medical devices as a potential risk to patients that manufacturers of medical devices must mitigate or eliminate. This session will describe the regulatory approach Health Canada is taking, what safety standards are relevant for this topic, and examples of industry approaches to medical device cybersecurity.
Learning Objective : At the conclusion of this session, participants should be able to:
Speaker(s)
Standards Landscape for Medical Device Cybersecurity
Laura Élan, RAC
CSA Group, United States
Senior Manager, Cybersecurity
Product Security Overview from a Medical Device Manufacturer
Colin Morgan
Johnson & Johnson, United States
Director, Product Security & Services
Session 5: Track A: Cybersecurity
Marc Lamoureux
Health Canada, Canada
Manager, Digital Health Division, Medical Devices Directorate